| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/06/2000 | CA2356671A1 Protease inhibitors |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356622A1 Compounds which affect mrna stability and uses therefor |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356548A1 Human brainiac-5 |
| 07/06/2000 | CA2356547A1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia |
| 07/06/2000 | CA2356542A1 Peptidoglycan recognition proteins |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356399A1 Anthraquinone anticancer drugs |
| 07/06/2000 | CA2356319A1 Thyroid receptor ligands |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2355744A1 Novel inhibitors of farnesyl-protein transferase |
| 07/06/2000 | CA2355096A1 Treatment and diagnosis of cancer using inositolphosphoglycans antagonists |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2351357A1 Use of at-1 receptor antagonist or at-2 receptor modulator for treating diseases associated with an increase of at-1 or at-2 receptors |
| 07/06/2000 | CA2334958A1 Peptide mimics useful for treating disease |
| 07/05/2000 | EP1016715A1 Oligonucleotides having a conserved G4 core sequence |
| 07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/05/2000 | EP1016413A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/05/2000 | EP1015884A1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015588A1 Cell growth regulator |
| 07/05/2000 | EP1015586A2 Tie receptor tyrosine kinase ligand homologues |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015583A2 Protein containing an srcr domain |
| 07/05/2000 | EP1015578A1 Therapeutic molecules |
| 07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015492A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 07/05/2000 | EP1015474A1 Don-1 gene and polypeptides and uses therefor |
| 07/05/2000 | EP1015472A1 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases |
| 07/05/2000 | EP1015471A1 Hypoxia-regulated genes |
| 07/05/2000 | EP1015469A2 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 07/05/2000 | EP1015468A1 Follistatin-3 |
| 07/05/2000 | EP1015465A2 Hydrophobic glycosylamine derivatives, compositions, and methods for use |
| 07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 07/05/2000 | EP1015459A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 07/05/2000 | EP1015448A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods |
| 07/05/2000 | EP1015439A1 Prenyl transferase inhibitors |
| 07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 07/05/2000 | EP1015427A1 Substituted 2-pyrrolidinone activators of pkc |
| 07/05/2000 | EP1015423A1 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs |
| 07/05/2000 | EP1015413A1 Anti-cancer compounds |
| 07/05/2000 | EP1015036A1 Improvements in or relating to expression of immunogenic substances |
| 07/05/2000 | EP1015033A2 Substituted perylenequinones for use in photodynamic therapy |
| 07/05/2000 | EP1015031A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/05/2000 | EP1015030A2 Photochemotherapeutic compositions |
| 07/05/2000 | EP1015029A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent |
| 07/05/2000 | EP1015015A1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 07/05/2000 | EP1015014A1 Methods and compositions for inhibiting angiogenesis |
| 07/05/2000 | EP1015012A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
| 07/05/2000 | EP1015006A2 Cocoa extract compounds and methods for making and using the same |
| 07/05/2000 | EP1014990A1 Method of treating a tumor |
| 07/05/2000 | EP1014984A1 Inhibitors of prenyl-protein transferase |
| 07/05/2000 | EP1014982A1 Troglitazone compounds for treating climacteric |
| 07/05/2000 | EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
| 07/05/2000 | EP1014967A1 Use of zinc salts of conjugated linoleic acids to treat skin disorders |
| 07/05/2000 | EP1014953A2 Formulations for hydrophobic pharmaceutical agents |
| 07/05/2000 | EP1014945A1 Cationic lipid compositions targeting angiogenic endothelial cells |
| 07/05/2000 | EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/05/2000 | EP0565621B1 Method of making camptothecin and camptothecin analogs |
| 07/05/2000 | CN1259139A Prevention and treatment of hepatocellular cancer |
| 07/05/2000 | CN1259125A Substituted 3-cyano quinolines |
| 07/05/2000 | CN1259120A Calcilytic compounds |
| 07/05/2000 | CN1258740A Recombined adhenovirus expressing human interleukin 12 and its preparation and use |
| 07/05/2000 | CN1258739A Recombined adenovirus expressing human interleukin 18 and its preparation and use |
| 07/05/2000 | CN1258677A Synthesis and anticancer activity of conjugated phospholipid |
| 07/05/2000 | CN1258512A Lycium chinense glycopeptide and its production process |
| 07/05/2000 | CN1258506A Nonatungsten trititanium silicate used as antineoplastic medicine |
| 07/05/2000 | CN1054048C Oral liquid for treating cancer and its preparing process |
| 07/04/2000 | US6084095 Including 6-amino-4-(3-bromoanilino)pyrido(3,2-d)pyrimidine; 4-(3-bromoanilino)-6-methylaminopyrido (3,2-d)pyrimidine; and 4-(3-bromoanilino)-6-methylaminopyrido(3,2-d)pyrimidine; useful in treating proliferative diseases such as cancer |
| 07/04/2000 | US6084090 Human papilloma virus anti-sense oligonucleotides |
| 07/04/2000 | US6084088 Polynucleotides encoding novel tumor antigens |
| 07/04/2000 | US6084085 Inducing resistance to tumor growth with soluble IGF-1 receptor |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6083971 Certain oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 07/04/2000 | US6083956 Optically pure androgen mediator |
| 07/04/2000 | US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083936 Treatment of estrogen-dependent disorders such as estrogen-dependent cancers; also useful in diagnostic techniques such as magnetic resonance imaging and magnetic resonance spectroscopy |
| 07/04/2000 | US6083931 Method of inhibiting cancer metastasis |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2000 | US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 07/04/2000 | US6083917 Farnesyltransferase inhibitor peptide having specified tetrapeptide sequence |
| 07/04/2000 | US6083915 Method for treating liver cancer |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
| 07/04/2000 | US6083746 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083745 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/04/2000 | US6083510 High molecular weight extracts of Convolvulus arvensis field (field bindweed) |
| 07/04/2000 | US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells |
| 07/04/2000 | US6083480 Calcitonin receptor binding reagents |
| 07/04/2000 | US6083477 Useful therapeutic reagents for treating leukemias and lymphomas;conjugate of a non-immunogenic rnase or a therapeutic radionuclide that is an alpha-emitter or a beta-emitter and a cell-specific cytokine |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037927A1 High energy phototherapeutic agents |